WallStSmart
ANIX

Anixa Biosciences Inc

NASDAQ: ANIX · HEALTHCARE · BIOTECHNOLOGY

$3.00
+4.17% today

Updated 2026-04-30

Market cap
$100.58M
P/E ratio
P/S ratio
377.78x
EPS (TTM)
$-0.32
Dividend yield
52W range
$2 – $5
Volume
0.1M

Anixa Biosciences Inc (ANIX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-1.85M$-2.40M$-901868.00$-2.50M$-2.41M$-716000.00$-3.14M$-3.19M$-2.38M$1.36M$-3.38M$-3.80M$-4.27M$-4.74M$-6.18M$-4.94M$-6.49M$-6.21M$-7.33M$-7.17M
Capital expenditures$11024.00$13459.00$13853.00$1936.00$2069.00$9028.00$1600.00$0.00$6684.00$54776.00$146521.00$30188.00$38404.00$175457.00$15791.00$0.00$0.00$0.00$0.00$0.00
Depreciation
Stock-based comp$4.80M$4.58M$2.66M$786016.00$614914.00$2.69M$3.15M$2.68M$873561.00$1.67M$8.58M$5.52M$3.92M$7.50M$6.00M$4.42M$4.42M$3.68M
Free cash flow$-1.86M$-2.41M$-915721.00$-2.50M$-2.41M$-725028.00$-3.14M$-3.19M$-2.39M$1.31M$-3.53M$-3.83M$-4.31M$-4.92M$-6.19M$-4.94M$-6.49M$-6.21M$-7.33M$-7.17M
Investing cash flow
Financing cash flow
Dividends paid$29468.00$68211.00$33507.00$13463.00$851.00$16400.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$-320076.00$-434347.00$558479.00$2.46M$1.01M$-1.88M$851051.00$-283484.00$435735.00$2.93M$-16.77M